May 2019

FIRST MEDICINAL CANNABIS TRIAL TO TREAT TOURETTE’S SYNDROME BRINGS HOPE TO AUSTRALIAN PATIENTS

Chris Wright, Brisbane local who was diagnosed with Tourette’s syndrome at the age of 12 is one of the first patients recruited for the trial run by Brisbane’s Wesley Medical Research. The trial aims to assess the effects of medicinal cannabis on symptoms such as uncontrollable physical and/or verbal ticks. Read the article here.

ANTG appoints new Business Operations Manager   Australian Natural Therapeutics […]

READ MORE >

ANTG’s Eve Cannabis product reveals its potential to kill or inhibit cancer cells without impacting normal cells…

READ MORE >

ANTG has listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG).

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >